Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Pechère

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2001
Patients' interviews and misuse of antibioticsJ C Pechère
International Journal of Antimicrobial Agents|September 28, 2001
Macrolide resistance mechanisms in Gram-positive cocciJ C Pechère
Drugs|January 1, 1993
Quinolones in intracellular infectionsJ C Pechère
La Revue Du Praticien|September 21, 1982
[Compounds of the beta-lactam group as inhibitors of beta-lactamases]J C Pechère
Diagnostic Microbiology and Infectious Disease|May 1, 1992
Clinical evaluation of roxithromycin 300 mg once daily as an alternative to 150 mg twice dailyJ C Pechère
Bulletin De L'Academie Nationale De Medecine|May 1, 1993
[Microbiology of nosocomial infections]J C Pechère
Infection|September 1, 1989
Resistance to third generation cephalosporins: the current situationJ C Pechère
Drugs|January 1, 1988
Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responsesJ C Pechère
Pathologie-Biologie|February 1, 1986
[Lincosamides]J C Pechère
The Japanese Journal of Antibiotics|February 11, 2003
Azithromycin reduces the production of virulence factors in Pseudomonas aeruginosa by inhibiting quorum sensingJ C Pechère
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2001
Patients' interviews and misuse of antibioticsJ C Pechère
International Journal of Antimicrobial Agents|September 28, 2001
Macrolide resistance mechanisms in Gram-positive cocciJ C Pechère
Drugs|January 1, 1993
Quinolones in intracellular infectionsJ C Pechère
La Revue Du Praticien|September 21, 1982
[Compounds of the beta-lactam group as inhibitors of beta-lactamases]J C Pechère
Diagnostic Microbiology and Infectious Disease|May 1, 1992
Clinical evaluation of roxithromycin 300 mg once daily as an alternative to 150 mg twice dailyJ C Pechère
Bulletin De L'Academie Nationale De Medecine|May 1, 1993
[Microbiology of nosocomial infections]J C Pechère
Infection|September 1, 1989
Resistance to third generation cephalosporins: the current situationJ C Pechère
Drugs|January 1, 1988
Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responsesJ C Pechère
Pathologie-Biologie|February 1, 1986
[Lincosamides]J C Pechère
The Japanese Journal of Antibiotics|February 11, 2003
Azithromycin reduces the production of virulence factors in Pseudomonas aeruginosa by inhibiting quorum sensingJ C Pechère
Pageof 13